Maternus-Kliniken【MAK】銘柄情報 | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
ドイツ
TG
Maternus-Kliniken AG (MAK) 銘柄情報

Maternus-Kliniken AG (MAK)

1.66

0.07

(4.40%)

終了 12月5日 6:00AM

リアルタイムデータ

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.66

買値

1.52

売値

1.66

出来高

200

1.66 日の範囲 1.66

0.00 52 週間の範囲 0.00

時価総額

前日終値

1.59

始値

1.66

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

20,970,000

配当利回り

-

PER

-3.43

1 株当たり利益 (EPS)

-0.68

歳入

114.94M

純利益

-14.26M

セクター

Hospital & Medical Svc Plans

業界

Hospital & Medical Svc Plans

ウェブサイト

www.maternus.de

本社

Berlin, Deu

設立

-

Maternus-Kliniken AG is listed in the Hospital & Medical Svc Plans sector of the Tradegate (DE) with ticker MAK. The last closing price for Maternus-Kliniken was 1.59 €. Over the last year, Maternus-Kliniken shares have traded in a share price range of 0.00 € to 0.00 €.

Maternus-Kliniken currently has 20,970,000 shares in issue. The market capitalisation of Maternus-Kliniken is 33.34 € million. Maternus-Kliniken has a price to earnings ratio (PE ratio) of -3.43.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
P1MOrdinary Shares	0.771 € (2,012.33%)	11.77k
BLEBluebird bio Inc	0.6568 € (92.33%)	191.66k
PA8Paion AG	0.0184 € (58.62%)	27.5k
9SCManganese X Energy Corp	0.0374 € (50.81%)	54k
SQHSpearmint Resources Inc	0.017 € (41.67%)	581.39k
4E2Relmada Therapeutics Inc	0.605 € (-77.08%)	51.57k
L7C2Windfall Geotek Inc	0.0035 € (-58.82%)	150.12k
R1EAEV Resources Ltd	0.0014 € (-46.15%)	38k
BVU3St James Gold Corp	0.065 € (-39.25%)	10k
UH7ATennant Minerals NL	0.007 € (-39.13%)	20k
PF8European Lithium Limited	0.0318 € (-21.67%)	24.15M
D7GNel ASA	0.2699 € (8.92%)	7.96M
AXIAtos SE	0.3199 € (-25.78%)	4.47M
BT81PowerHouse Energy Group Plc	0.0124 € (0.00%)	1.85M
I5RImage Resources NL	0.059 € (7.27%)	1.78M

Astro26

Astro26 4分前

Release the fins Zooey...

JoJr

Just met link in another play but yes, he is quite a character.

dstock07734

dstock07734 5分前

Since INmune Bio Inc. has product related to dendritic cells and Kelly Ganjei is a board member, this news is relevant.

OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower
https://www.omnis

norisknorewards

norisknorewards 5分前

you're high if you think NW is paying me, the name fits you

Steady_T

Steady_T 5分前

That fact that you are ASSUMING that the time taken by regulatory and courts leads to a negative conclusion is a red flag on your posts.

dreamaker56

dreamaker56 6分前

Dave claimed in his X post that Financials would be posted along with a PR, that was a week+ ago. All I hear is crickets and more snotty replies to people calling him out. Company is run by an immature baby....or a really smart dude that got all our money.

iamthe walrus

iamthe walrus 6分前

Junk ?? expected to exceed 100 million in revenue annually per today's press release. Why is this stock junk in your eyes ? I respect other opinions but we need to know why you see this as junk. Many of us have been involved for years now and today's news was another good step forward. Everyone that

iamthe walrus

iamthe walrus 6分前

Junk ?? expected to exceed 100 million in revenue annually per today's press release. Why is this stock in your eyes ? I respect other opinions but we need to know why you see this as junk. Many of us have been involved for years now and today's news was another good step forward. Everyone that post

BIOCHEMUP

BIOCHEMUP 7分前

JoJr

Wowzers...

How do you figure that?

Lone Clone

Lone Clone 7分前

SNOWLINE GOLD INTERSECTS 386.0 M OF 1.1 GRAMS PER TONNE GOLD FROM SURFACE INCLUDING 120.5 M OF 2.0 GRAMS PER TONNE GOLD WITH ADDITIONAL STRONG INTERSECTIONS NEAR EDGES OF VALLEY RESOURCE

Hole V-24-096 returned 1.08 g/t Au over 386.0 m from surface, including 2.00 g/t Au over 120.5

northam43

northam43 7分前

Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/4/onbzp6.1_Short_Term.png

DiscoverGold

DiscoverGold 7分前

Gold Bear Flag Pattern Signals Potential Bearish Continuation
By: Bruce Powers | December 4, 2024

• Resistance at $2,666 and 50-Day MA challenges gold’s recovery, while bearish continuation may lead to drop below November’s swing low.

Gold has formed a devel

DiscoverGold

DiscoverGold 7分前

Gold Bear Flag Pattern Signals Potential Bearish Continuation
By: Bruce Powers | December 4, 2024

• Resistance at $2,666 and 50-Day MA challenges gold’s recovery, while bearish continuation may lead to drop below November’s swing low.

Gold has formed a devel

DrHigh

congrats on your employment. you do what you gotta do to put food on the table.

Filterthenoise

Filterthenoise 8分前

I bet many miss those billions on the ask🎅

Not shareholders

pantherj

pantherj 8分前

Where is that guy who told investors the price would never, ever drop below .09??

packerfan9

packerfan9 8分前

What nonsense. They sell shares. Billions over and over. Sale of product tiny. Like I said this will end up diluted back to .0001 again. They could never sell enough CBD to ever justify all the dilution since 2020. It's so over valued even if they sold millions and if they ever make a profit. They m

northam43

northam43 8分前

Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/4/onbzp6.1_Short_Term.png

IB_

You should buy more shares, Tommie Bee !!!!!!!!!!!!!!!!

IB_🤴

mrfence

mrfence 8分前

LOL @ Catman sucking up to shareholders by actually telling the truth on X that he should have told CNN.

Truth_is_a_tool

Truth_is_a_tool 9分前

”” In 2025 , we expect to produce more than 10,000 lbs of finished spider silk YARN. We expect to begin opening the doors for commercial sales of spider silk once we have 1.5 tons of spider silk YARN in inventory “”

“” the research and development phase of our flagship spider silk f

boo boo

boo boo 9分前

You have pathological egocentricity characteristics in my humble opinion.

IceCold8

IceCold8 9分前

Hey,MMS! The more you keep running the pps,back,and fourth,with this wash,rinse,and repeat, campaign that has persisted for years now,the more potential prospective investors you will detract! Furthermore,proving you could careless about your investors,and only care about lining your pockets.

Maternus-Kliniken

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約